Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements
暂无分享,去创建一个
M. Rocchi | L. Anelli | N. Coccaro | A. Zagaria | G. Specchia | F. Albano | L. Vicari | V. Liso | A. Rossi | Paola Casieri
[1] P. Sonneveld,et al. Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma. , 2010, Leukemia research.
[2] M. Rocchi,et al. Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia , 2010, Oncogene.
[3] Jianjun Chen,et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. , 2010, Blood cells, molecules & diseases.
[4] Teresa Colombo,et al. Characterization of B‐ and T‐lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles , 2009, Genes, chromosomes & cancer.
[5] Thomas Ried,et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. , 2009, Molecular cell.
[6] E. Montserrat,et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes , 2009, Leukemia & lymphoma.
[7] C. Croce,et al. Karyotype-specific microRNA signature in chronic lymphocytic leukemia. , 2009, Blood.
[8] M. Georges,et al. Methylation analysis of the imprinted DLK1-GTL2 domain supports the random parental origin of the IGH-involving del(14q) in B-cell malignancies , 2009, Epigenetics.
[9] A. Saâd,et al. Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. , 2009, Cancer genetics and cytogenetics.
[10] L. Harries,et al. Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL) , 2009, PloS one.
[11] O. Hermine,et al. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. , 2009, Blood.
[12] D. Marin,et al. FISH mapping of Philadelphia negative BCR/ABL1 positive CML , 2008, Molecular Cytogenetics.
[13] M. Rocchi,et al. The double deceit generated by an insertion mechanism in chronic myeloid leukemia with t(9;9;22) , 2008, Annals of Hematology.
[14] Jean-Baptiste Cazier,et al. Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia , 2008, PloS one.
[15] V. Eclache,et al. Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy. , 2008, Cancer genetics and cytogenetics.
[16] D. Marin,et al. Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements. , 2008, Cancer genetics and cytogenetics.
[17] George A Calin,et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. , 2008, Blood.
[18] Junia V. Melo,et al. Chronic myeloid leukaemia as a model of disease evolution in human cancer , 2007, Nature Reviews Cancer.
[19] N. Archidiacono,et al. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia. , 2007, Cancer genetics and cytogenetics.
[20] Zihai Li,et al. On the genesis and prognosis of variant translocations in chronic myeloid leukemia. , 2007, Cancer genetics and cytogenetics.
[21] Peter A. Jones,et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.
[22] M. Rocchi,et al. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. , 2006, Cancer genetics and cytogenetics.
[23] E. Campo,et al. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia. , 2006, Cancer genetics and cytogenetics.
[24] A. Moorman,et al. Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG‐richest regions of the genome , 2005, Genes, chromosomes & cancer.
[25] H. Kantarjian,et al. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. , 2005, Blood.
[26] G. Cuthbert,et al. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia. , 2004, Cancer genetics and cytogenetics.
[27] M. Rocchi,et al. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. , 2004, Cancer genetics and cytogenetics.
[28] M. Rocchi,et al. Derivative Chromosome 9 Deletions in Chronic Myeloid Leukemia are Associated with Loss of Tumor Suppressor Genes , 2004, Leukemia & lymphoma.
[29] H. Kantarjian,et al. Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome , 2004, British journal of haematology.
[30] M. Rocchi,et al. A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11). , 2004, Cancer genetics and cytogenetics.
[31] A. Green,et al. Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions. , 2003, Blood.
[32] A. Green,et al. Survival implications of molecular heterogeneity in variant Philadelphia‐positive chronic myeloid leukaemia , 2003, British journal of haematology.
[33] M. Rocchi,et al. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases , 2003, Genes, chromosomes & cancer.
[34] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Rocchi,et al. Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients , 2002, Genes, chromosomes & cancer.
[36] J. Squire,et al. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors , 2002, Genes, chromosomes & cancer.
[37] M. Rocchi,et al. Molecular cytogenetic characterization of a complex rearrangement involving chromosomes 9 and 22 in a case of Ph-negative chronic myeloid leukemia. , 2002, Cancer genetics and cytogenetics.
[38] C. Morris,et al. Nonrandom distribution of interspersed repeat elements in the BCR and ABL1 genes and its relation to breakpoint cluster regions , 2001, Genes, chromosomes & cancer.
[39] A. Chase,et al. Cytogenetics of chronic myeloid leukaemia. , 2001, Best practice & research. Clinical haematology.
[40] K. S. Reddy,et al. A Philadelphia-negative chronic myeloid leukemia with a BCR/ABL fusion gene on chromosome 9. , 1998, Cancer genetics and cytogenetics.
[41] C. Morris,et al. Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement? , 1991, Cancer genetics and cytogenetics.
[42] A. Hagemeijer,et al. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. , 1991, Cancer genetics and cytogenetics.
[43] J. Huret. Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia , 1990, Human Genetics.
[44] G Hermanson,et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. , 1990, Science.
[45] A. Daniel. Structural differences in reciprocal translocations , 1979, Human Genetics.
[46] L. Shaffer,et al. ISCN 2009 - An International System for Human Cytogenetic Nomenclature , 2009 .
[47] M. Zago,et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[48] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .